首页> 美国卫生研究院文献>Reproductive Biology and Endocrinology : RBE >Mixed protocols: Multiple ratios of FSH and LH bioactivity using highly purified human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe
【2h】

Mixed protocols: Multiple ratios of FSH and LH bioactivity using highly purified human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe

机译:混合方案:使用同一注射器中的高纯度人源性FSH(BRAVELLE)和高纯度hMG(MENOPUR)可以实现多种比率的FSH和LH生物活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe use of mixed or blended protocols, that utilize both FSH and hMG, for controlled ovarian hyperstimulation is increasing in use. To reduce the number of injections a patient must administer, many physicians instruct their patients to mix their FSH and hMG together to be given as a single injection. Therefore, the goal of this study was to definitively determine if the FSH and LH bioactivities of highly purified, human-derived FSH (Bravelle(R)) and highly purified hMG (Menopur(R)) were altered by reconstituting in 0.9% saline and mixing in the same syringe.
机译:背景技术利用FSH和hMG的混合或混合方案来控制卵巢过度刺激的使用正在增加。为了减少患者必须进行的注射次数,许多医生指示其患者将他们的FSH和hMG混合在一起作为单次注射。因此,这项研究的目的是确定是否通过在0.9%的生理盐水中重新配制来改变高度纯化的人源性FSH(Bravelle?)和高度纯化的hMG(Menopur?)的FSH和LH生物活性。在同一注射器中混合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号